Detection of antibodies to HTLV-III in commercially available immunoglobulin preparations |
| |
Authors: | R. Kurth I. Schmidt A. Werner G. von Wangenheim J. Löwer H. -D. Brede |
| |
Affiliation: | (1) Paul-Ehrlich-Institut, Germany;(2) Chemotherapeutisches Forschungsinstitut, Georg-Speyer-Haus, Frankfürt am Main |
| |
Abstract: | Summary Samples of 96 polyvalent and virus-specific immunoglobulin batches commercially available in West-Germany were tested by enzyme-linked immunoassay and immunoblot for the presence of anti-HTLV-III antibodies. 37% of the polyvalent and 87% of the virus-specific batches were positive. It was concluded that these preparations are still safe and because of their reportedly low titer neutralizing antibodies possibly beneficial in certain cases, such as newborns of HTLV-III positive mothers or after accidental exposure to infectious material in clinics or laboratories.Abbreviations AIDS acquired immunodeficiency syndrome - ARC AIDS-related complex - CMV cytomegalovirus - ELISA enzyme-linked immuno adsorbent assay - HTLV-III human T-cell lymphotropic virus, type III |
| |
Keywords: | HTLV-III Antibodies to HTLV-III Commercial immunoglobulin preparations |
本文献已被 SpringerLink 等数据库收录! |